最新报道:Injective (INJ) has surged 59% over the past 90 days, mirroring Chainlink's (LINK) early 2024 rally pattern. The token's price action shows striking similarities to LINK's breakout earlier this year, which preceded a 250% gain. Analysts note both assets exhibited strong accumulation phases before their respective rallies, with INJ currently testing key resistance levels. The parallel suggests potential for further upside if INJ follows LINK's trajectory. Market observers attribute the momentum to growing adoption of Injective's decentralized finance infrastructure and increasing institutional interest in layer-1 blockchain solutions.